Uncommon · Knowledge
Vildagliptin
Chemical compound
Vildagliptin, sold under the brand name Galvus among others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
From Wikipedia
Vildagliptin, sold under the brand name Galvus among others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas. Bold textIt was approved by the European Medicines Agency (EMA) in 2007. The European Medicines Agency has also approved a combination of vildagliptin and metformin, vildagliptin/metformin (Eucreas by Novartis) as an oral treatment for type-2 diabetes. Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.
Text: Wikipédia, CC BY-SA 4.0. · Image: Fvasconcellos (Public domain) ·
Related cards
-
★★
Dipeptidyl peptidase-4 inhibitor
Compounds that suppress the degradation of incretins by blocking the action of dipeptidyl-peptidase 4
-
★★
Alogliptin
Chemical compound
-
★★
Diabetes medication
Substances which lower blood glucose levels
-
★★
Liraglutide
Pharmaceutical drug
-
★
Dalbavancin
Antibiotic used to treat MRSA
-
★★★
Orforglipron
Chemical compound